These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 33464558)
21. Benefits of Systemic Anti-inflammatory Therapy versus Fluocinolone Acetonide Intraocular Implant for Intermediate Uveitis, Posterior Uveitis, and Panuveitis: Fifty-four-Month Results of the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study. ; Kempen JH; Altaweel MM; Drye LT; Holbrook JT; Jabs DA; Sugar EA; Thorne JE Ophthalmology; 2015 Oct; 122(10):1967-75. PubMed ID: 26298715 [TBL] [Abstract][Full Text] [Related]
22. The Outcomes of Switching from Short- to Long-Term Intravitreal Corticosteroid Implant Therapy in Patients with Diabetic Macular Edema. Vaz-Pereira S; Castro-de-Sousa JP; Martins D; Prates Canelas J; Reis P; Sampaio A; Urbano H; Kaku P; Nascimento J; Marques-Neves C Ophthalmic Res; 2020; 63(2):114-121. PubMed ID: 31801148 [TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of dexamethasone intravitreal implant in patients with retinal vein occlusion resistant to anti-VEGF therapy: a 12-month prospective study. Georgalas L; Tservakis I; Kiskira EE; Petrou P; Papaconstantinou D; Kanakis M Cutan Ocul Toxicol; 2019 Dec; 38(4):330-337. PubMed ID: 31060385 [No Abstract] [Full Text] [Related]
24. Sustained Control from Recurring Non-Infectious Uveitic Macular Edema with 0.19 mg Fluocinolone Acetonide Intravitreal Implant - A Case Report. Meira J; Madeira C; Falcão-Reis F; Figueira L Ophthalmol Ther; 2019 Dec; 8(4):635-641. PubMed ID: 31506865 [TBL] [Abstract][Full Text] [Related]
25. The use of vascular endothelial growth factor inhibitor for choroidal neovascularization complicating posterior uveitis in eyes with fluocinolone acetonide implants. Lee ST; Gupta SR; Richards AB; Suhler EB; Smith JR; Flaxel CJ Retin Cases Brief Rep; 2013; 7(1):35-40. PubMed ID: 25390518 [TBL] [Abstract][Full Text] [Related]
26. Fluocinolone Implant for Idiopathic Retinal Vasculitis, Aneurysms, and Neuroretinitis Syndrome: A Case Report. Moreno-Castro L; García-García GP; Artaraz J; Fonollosa A Case Rep Ophthalmol; 2021; 12(3):824-830. PubMed ID: 34720984 [TBL] [Abstract][Full Text] [Related]
27. Efficacy of the Fluocinolone Acetonide (Yutiq) Intravitreal Implant as Monotherapy for Uveitis. Mahmud H; Ahmad TR; Gonzales JA; Stewart JM Ocul Immunol Inflamm; 2023 Oct; 31(8):1603-1607. PubMed ID: 35793136 [TBL] [Abstract][Full Text] [Related]
28. Long-term results of fluocinolone acetonide intravitreal implant in Behçet intractable posterior uveitis. Oh EK; Lee EK; Yu HG Can J Ophthalmol; 2014 Jun; 49(3):273-8. PubMed ID: 24862774 [TBL] [Abstract][Full Text] [Related]
32. Report of 12-months efficacy and safety of intravitreal fluocinolone acetonide implant for the treatment of chronic diabetic macular oedema: a real-world result in the United Kingdom. Alfaqawi F; Lip PL; Elsherbiny S; Chavan R; Mitra A; Mushtaq B Eye (Lond); 2017 Apr; 31(4):650-656. PubMed ID: 28106887 [TBL] [Abstract][Full Text] [Related]
33. Cost-effectiveness of fluocinolone acetonide implant (ILUVIEN®) in UK patients with chronic diabetic macular oedema considered insufficiently responsive to available therapies. Pochopien M; Beiderbeck A; McEwan P; Zur R; Toumi M; Aballéa S BMC Health Serv Res; 2019 Jan; 19(1):22. PubMed ID: 30626376 [TBL] [Abstract][Full Text] [Related]
34. A comparison between the fluocinolone acetonide (Retisert) and dexamethasone (Ozurdex) intravitreal implants in uveitis. Arcinue CA; Cerón OM; Foster CS J Ocul Pharmacol Ther; 2013 Jun; 29(5):501-7. PubMed ID: 23297752 [TBL] [Abstract][Full Text] [Related]
35. Evaluation of the clinical effectiveness of fluocinolone acetonide 190 µg intravitreal implant in diabetic macular edema: a comparison between study and fellow eyes. Currie CJ; Holden SE; Berni E; Owens DR Curr Med Res Opin; 2017 Oct; 33(sup2):19-31. PubMed ID: 28881143 [TBL] [Abstract][Full Text] [Related]
36. Intravitreal triamcinolone acetonide for treatment of cystoid macular oedema in patients with retinitis pigmentosa. Ozdemir H; Karacorlu M; Karacorlu S Acta Ophthalmol Scand; 2005 Apr; 83(2):248-51. PubMed ID: 15799743 [TBL] [Abstract][Full Text] [Related]
37. Intravitreal fluocinolone acetonide implant (ILUVIEN®) for diabetic macular oedema: a literature review. Massa H; Nagar AM; Vergados A; Dadoukis P; Patra S; Panos GD J Int Med Res; 2019 Jan; 47(1):31-43. PubMed ID: 30556449 [TBL] [Abstract][Full Text] [Related]
38. Fluocinolone acetonide sustained drug delivery device to treat severe uveitis. Jaffe GJ; Ben-Nun J; Guo H; Dunn JP; Ashton P Ophthalmology; 2000 Nov; 107(11):2024-33. PubMed ID: 11054326 [TBL] [Abstract][Full Text] [Related]
39. Patterns of retinal thickness prior to and following treatment with fluocinolone acetonide 190 µg intravitreal implant for diabetic macular edema. Currie CJ; Holden SE; Owens DR Curr Med Res Opin; 2017 Oct; 33(sup2):33-43. PubMed ID: 28881150 [TBL] [Abstract][Full Text] [Related]